메뉴 건너뛰기
Journal of Clinical Oncology
Volumn 26, Issue 15, 2008, Pages 2582-2584
Bilateral eardrum perforation after long-term treatment with erlotinib
Author keywords

[No Author keywords available]
Indexed keywords

CARBOPLATIN; ERLOTINIB; FLUORODEOXYGLUCOSE F 18; GEMCITABINE; ANTINEOPLASTIC AGENT; QUINAZOLINE DERIVATIVE;
EID: 45149109106     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2007.15.3387     Document Type: Article
Times cited : (7)
References (11)
  • 1
    • 2342471392 scopus 로고    scopus 로고
    • Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib
    • Lynch TJ, Bell DW, Sordella R, et al: Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med 350:2129-2139, 2004
    • (2004) N Engl J Med , vol.350 , pp. 2129-2139
    • Lynch, T.J.1    Bell, D.W.2    Sordella, R.3
  • 2
    • 2342624080 scopus 로고    scopus 로고
    • EGFR mutations in lung cancer: Correlation with clinical response to gefitinib therapy
    • Paez JG, Janne PA, Lee JC, et al: EGFR mutations in lung cancer: Correlation with clinical response to gefitinib therapy. Science 304:1497-1500, 2004
    • (2004) Science , vol.304 , pp. 1497-1500
    • Paez, J.G.1    Janne, P.A.2    Lee, J.C.3
  • 3
    • 20044370274 scopus 로고    scopus 로고
    • Skin rash and good performance status predict improved survival with gefitinib in patients with advanced non-small cell lung cancer
    • Mohamed MK, Ramalingam S, Lin Y, et al: Skin rash and good performance status predict improved survival with gefitinib in patients with advanced non-small cell lung cancer. Ann Oncol 16:780-785, 2005
    • (2005) Ann Oncol , vol.16 , pp. 780-785
    • Mohamed, M.K.1    Ramalingam, S.2    Lin, Y.3
  • 4
    • 22044445517 scopus 로고    scopus 로고
    • Erlotinib in previously treated non-small-cell lung cancer
    • Shepherd FA, Rodrigues Pereira J, Ciuleanu T, et al: Erlotinib in previously treated non-small-cell lung cancer. N Engl J Med 353:123-132, 2005
    • (2005) N Engl J Med , vol.353 , pp. 123-132
    • Shepherd, F.A.1    Rodrigues Pereira, J.2    Ciuleanu, T.3
  • 5
    • 33748445361 scopus 로고    scopus 로고
    • Symptom improvement in lung cancer patients treated with erlotinib: Quality of life analysis of the National Cancer Institute of Canada Clinical Trials Group Study BR21
    • Bezjak A, Tu D, Seymour L, et al: Symptom improvement in lung cancer patients treated with erlotinib: Quality of life analysis of the National Cancer Institute of Canada Clinical Trials Group Study BR21. J Clin Oncol 24:3831-3837, 2006
    • (2006) J Clin Oncol , vol.24 , pp. 3831-3837
    • Bezjak, A.1    Tu, D.2    Seymour, L.3
  • 6
    • 0033762498 scopus 로고    scopus 로고
    • The EGF receptor: An essential regulator of multiple epidermal functions
    • Jost M, Kari C, Rodeck U: The EGF receptor: An essential regulator of multiple epidermal functions. Eur J Dermatol 10:505-510, 2000
    • (2000) Eur J Dermatol , vol.10 , pp. 505-510
    • Jost, M.1    Kari, C.2    Rodeck, U.3
  • 7
    • 0025073305 scopus 로고
    • Epidermal growth factor binding and action on tympanic membranes
    • O'Daniel TG, Petitjean M, Jones SC, et al: Epidermal growth factor binding and action on tympanic membranes. Ann Otol Rhinol Laryngol 99:80-84, 1990
    • (1990) Ann Otol Rhinol Laryngol , vol.99 , pp. 80-84
    • O'Daniel, T.G.1    Petitjean, M.2    Jones, S.C.3
  • 8
    • 0031798793 scopus 로고    scopus 로고
    • Growth factors in tympanic membrane perforations
    • Somers T, Goovaerts G, Schelfhout L, et al: Growth factors in tympanic membrane perforations. Am J Otol 19:428-434, 1998
    • (1998) Am J Otol , vol.19 , pp. 428-434
    • Somers, T.1    Goovaerts, G.2    Schelfhout, L.3
  • 9
    • 0028125592 scopus 로고
    • Repair of chronic tympanic membrane perforations using epidermal growth factor: Progress toward clinical application
    • Lee AJ, Jackler RK, Kato BM, et al: Repair of chronic tympanic membrane perforations using epidermal growth factor: Progress toward clinical application. Am J Otol 15:10-18, 1994
    • (1994) Am J Otol , vol.15 , pp. 10-18
    • Lee, A.J.1    Jackler, R.K.2    Kato, B.M.3
  • 10
    • 33746852125 scopus 로고    scopus 로고
    • Healing of subacute tympanic membrane perforations in chinchillas treated with epidermal growth factor and pentoxifylline
    • Ramalho JR, Bento RF: Healing of subacute tympanic membrane perforations in chinchillas treated with epidermal growth factor and pentoxifylline. Otol Neurotol 27:720-727, 2006
    • (2006) Otol Neurotol , vol.27 , pp. 720-727
    • Ramalho, J.R.1    Bento, R.F.2
  • 11
    • 33846581948 scopus 로고    scopus 로고
    • Inhibition of epidermal growth factor receptor by erlotinib: Wound healing of experimental tympanic membrane perforations
    • Kaftan H, Vogelgesang S, Lempas K, et al: Inhibition of epidermal growth factor receptor by erlotinib: Wound healing of experimental tympanic membrane perforations. Otol Neurotol 28:245-249, 2007
    • (2007) Otol Neurotol , vol.28 , pp. 245-249
    • Kaftan, H.1    Vogelgesang, S.2    Lempas, K.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.